CS logo
small CS logo
Kantonsspital Winterthur Medizinische Onkologie

Winterthur, Switzerland
Krankenhaus in Winterthur

About Kantonsspital Winterthur Medizinische Onkologie


Das Kantonsspital Winterthur dient der medizinischen Versorgung der Region Winterthur im Kanton Zürich. Die öffentlich-rechtliche Einrichtung ist mit rund 500 Betten der zehntgrösste Spitalbetrieb in der Schweiz und behandelt jährlich rund 200'000 stationäre und ambulante Patienten.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Kantonsspital Winterthur Medizinische Onkologie


During the past decade, Kantonsspital Winterthur Medizinische Onkologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Kantonsspital Winterthur Medizinische Onkologie


According to Clinical.Site data, the most researched conditions in "Kantonsspital Winterthur Medizinische Onkologie" are "Breast Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Kantonsspital Winterthur Medizinische Onkologie" in a lesser frequency.

Clinical Trials Intervention Types at Kantonsspital Winterthur Medizinische Onkologie


Most popular intervention types in "Kantonsspital Winterthur Medizinische Onkologie" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Gemcitabine" (2 trials), "Neratinib" (2 trials), "Paclitaxel" (2 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kantonsspital Winterthur Medizinische Onkologie


The vast majority of trials in "Kantonsspital Winterthur Medizinische Onkologie" are 4 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Kantonsspital Winterthur Medizinische Onkologie


Currently, there are NaN active trials in "Kantonsspital Winterthur Medizinische Onkologie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kantonsspital Winterthur Medizinische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kantonsspital Winterthur Medizinische Onkologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".